Foghorn Therapeutics Inc Cash Flow Reinvestment Rate
Foghorn Therapeutics Inc cash flow reinvestment rate. Foghorn Therapeutics Inc (FHTX) has a Cash Flow Reinvestment Rate of 0.59x as of March 2022, reinvesting $159.41 Million (capex $247.00K plus investments $-159.16 Million) from operating cash flow of $271.53 Million. Explore FHTX debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Foghorn Therapeutics Inc (2022–2022)
Cash flow reinvestment rate of Foghorn Therapeutics Inc from 2022 to 2022. Historical reinvestment intensity for Foghorn Therapeutics Inc across 1 annual periods. Explore FHTX capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Foghorn Therapeutics Inc Cash Flow Reinvestment Rate by Year (2022–2022)
Foghorn Therapeutics Inc cash flow reinvestment rate by year from 2022 to 2022. Year-by-year capital reinvestment analysis for Foghorn Therapeutics Inc. For the full cash flow conversion analysis, see FHTX cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.26x | $244.32 Million | $193.61 Million | $1.21 Million | — |